A one-stop platform for pipeline development monitoring and clinical value evaluation from the perspective of indications
DeepMed™ constructs a one-stop knowledge platform centered on subdivided indications.
DeepMed™ is developed around a core concept called "subdivided indications" , which includes the concept of clinical stage, biomarker, pathology, baseline characteristics, etc.. With the combination of line (such as neoadjuvant, adjuvant, first-line, second-line, etc.), DeepMed™ provides a clear view of the pivotal trials, clinical outcomes, regulatory approvals, guideline-recommended regimens, and epidemiology etc., under each subdivided indications.
Pivotal trials
Be able to search pivotal trials by using biomarkers, lines etc., and get informed about the status of the trial, the clinical results, the related approval events, and the inclusion of guideline evidence.
Clinical outcomes
Abundant data sources and structured data help to clearly gather clinical results under subdivided indications. The clinical results are more comprehensive, and the endpoint results are clearer.
Regularoty approvals
To see the regulatory approval status of innovative drugs in China, the United States, and Europe under subdivided indications. The information includes special designations, review documents which is disclosed, and news for up-to-date approvals.
Guidline recommendations
To investigate the treatment regimens, support evidence and treatment pathways. And compare the differences in the recommended regimens of guidelines in different countries or regions, and understand the historical changes of guidelines.
Epidemiology
To understand the incidence, survival, mortality and other conditions of domestic and foreign patients under subdivided indications, and to assist in estimating market potential and clinical needs.
What's Special
More precise diease classification system
Dismantle indications to clinical stages, biomarkers, lines, etc.
Dismantle indications to clinical stages, biomarkers, lines, etc.
More accurate lines of treatment
Pipeline competitive landscape is able to search and sort by neoadjuvant, adjuvant, first line, second line, etc.
Pipeline competitive landscape is able to search and sort by neoadjuvant, adjuvant, first line, second line, etc.
More clear disease treatment pathway
The treatment map illustrate the clinical pathway and the supportive clinical trials with result.
The treatment map illustrate the clinical pathway and the supportive clinical trials with result.
More in-depth clinical results
Over 220,000 trial results and nearly 20,000 key results are reviewed by the analysts to provide more comprehensive information.
Over 220,000 trial results and nearly 20,000 key results are reviewed by the analysts to provide more comprehensive information.
More comprehensive epidemiology coverage
Epidemiological program by global or national authority and literature data for full disease area coverage.
Epidemiological program by global or national authority and literature data for full disease area coverage.
More reliable data processing cycle
Gather top-notch team in medical and pharmaceutical fields with in-depth scenario research and strict data quality control.
Gather top-notch team in medical and pharmaceutical fields with in-depth scenario research and strict data quality control.
